Clay B. Siegall - 18 Dec 2025 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
President and CEO, Director
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
18 Dec 2025
Net transactions value
+$999,986
Form type
4
Filing time
18 Dec 2025, 17:03:54 UTC
Previous filing
28 Oct 2025
Next filing
22 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SIEGALL CLAY B President and CEO, Director C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL /s/ Sandra Stoneman, Attorney-in-Fact 18 Dec 2025 0001167496

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Purchase $999,986 +46,511 +5.8% $21.50 853,247 18 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased the shares in connection with the Issuer's recently completed underwritten public offering of common stock.